製品の概要

  • 製品名Anti-SLC33A1 antibody
    SLC33A1 一次抗体 製品一覧
  • 製品の詳細
    Rabbit polyclonal to SLC33A1
  • アプリケーション適用あり: WBmore details
  • 種交差性
    交差種: Human
    交差が予測される動物種: Mouse, Rat, Rabbit, Horse, Chicken, Guinea pig, Cow, Cat, Dog, Zebrafish
  • 免疫原

    Synthetic peptide corresponding to a region within internal sequence amino acids 215-264 (CNSVGQTAGY FLGNVLFLAL ESADFCNKYL RFQPQPRGIV TLSDFLFFWG) of human SLC33A1 (NP_004724).

  • ポジティブ・コントロール
    • Human Placenta lysate.

製品の特性

  • 製品の状態Liquid
  • 保存方法Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
  • バッファーPreservative: None
    Constituents: 2% Sucrose, PBS
  • Concentration information loading...
  • 精製度Immunogen affinity purified
  • ポリ/モノポリクローナル
  • アイソタイプIgG
  • 研究分野

アプリケーション

Our Abpromise guarantee covers the use of ab83868 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

アプリケーション Abreviews 特記事項
WB Use a concentration of 1 µg/ml. Detects a band of approximately 61 kDa (predicted molecular weight: 61 kDa). Good results were obtained when blocked with 5% non-fat dry milk in 0.05% PBS-T.

ターゲット情報

  • 機能Probable acetyl-CoA transporter necessary for O-acetylation of gangliosides.
  • 組織特異性Ubiquitous. Detected in heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. With strongest signals in pancreas.
  • 関連疾患Spastic paraplegia autosomal dominant 42 (SPG42) [MIM:612539]: A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. Note=The disease is caused by mutations affecting the gene represented in this entry.
    Congenital cataracts, hearing loss, and neurodegeneration (CCHLND) [MIM:614482]: An autosomal recessive disorder characterized by congenital cataracts, severe psychomotor retardation, and hearing loss associated with decreased serum ceruloplasmin and copper. Brain MRI shows cerebral and cerebellar atrophy and hypomyelination. Note=The disease is caused by mutations affecting the gene represented in this entry.
  • 配列類似性Belongs to the SLC33A transporter family.
  • 細胞内局在Endoplasmic reticulum membrane.
  • Information by UniProt
  • 参照データベース
  • 別名
    • ACATN antibody
    • ACATN_HUMAN antibody
    • Acetyl CoA transporter antibody
    • Acetyl Coenzyme A transporter antibody
    • Acetyl coenzyme A transporter 1 antibody
    • Acetyl-CoA transporter 1 antibody
    • Acetyl-coenzyme A transporter 1 antibody
    • AT 1 antibody
    • AT-1 antibody
    • AT1 antibody
    • Human Angiotensin II Type 1 Receptor antibody
    • Slc33a1 antibody
    • Solute carrier family 33 (acetyl CoA transporter) member 1 antibody
    • Solute carrier family 33 member 1 antibody
    • spastic paraplegia 42 (autosomal dominant) antibody
    • SPG42 antibody
    see all

Anti-SLC33A1 antibody 画像

  • Anti-SLC33A1 antibody (ab83868) at 1 µg/ml (5% skim milk / PBS buffer) + Placenta lysate at 10 µg

    Secondary
    HRP conjugated anti-Rabbit IgG at 1/50000 dilution

    Predicted band size : 61 kDa
    Observed band size : 61 kDa

Anti-SLC33A1 antibody (ab83868) 使用論文

ab83868 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab83868.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"